We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New MRI Technique Reveals Fat Accumulation in Hearts of Pre-diabetics

By Biotechdaily staff writers
Posted on 17 Sep 2007
A simple imaging technique reveals fat buildup in the hearts of pre-diabetic people long before symptoms of heart disease or diabetes appear.

The modality identifies fat accumulation in cells of the beating heart in a way no other clinical method can, according to the researchers who developed the method, and may provide a way to screen patients for early signs of heart disease in diabetes.

"Hearts beat; people breathe; and magnetic resonance imaging [MRI] is very sensitive to motion, so we had to find a way to electronically ‘freeze' the image of the heart,” said Dr. More...
Lidia Szczepaniak, assistant professor of internal medicine at the University of Texas (UT) Southwestern Medical Center (Dallas, USA) and senior author of a study appearing in the September 4, 2007, issue of the journal Circulation.

Dr. Szczepaniak and her colleagues developed a technique that captures the signal from a beating heart as a person lies in an ordinary magnet used for MRI scanning. The researchers knew that fat builds up in the hearts of people with heart failure or non-insulin-dependent diabetes (type II) from earlier studies involving patients undergoing heart transplants, but they did not know if this fatty buildup occurred before or after the diabetic conditions developed.

In the new study, the UT Southwestern researchers used a conventional magnetic resonance imaging (MRI) system, but added the newly developed computer software to convert the signals from a moving heart into a single image. They looked at lean and obese individuals with normal blood sugar; obese people beginning to show abnormal sugar metabolism, and obese people with full-blown type II diabetes.

Their most significant finding, according to Dr. Dr. Szczepaniak, was that fat accumulation in the heart develops before the onset of diabetes. They also discovered that the amount of fat in the heart of individuals with abnormal sugar metabolism was considerably higher than in those with normal blood sugar, whether obese or lean. The amount of fat in the heart was unrelated to the amount of fat in the bloodstream or liver, indicating that measuring any of those factors could not predict accumulation of fat in the heart. Fat in the heart did correspond to the amount of fat in the stomach region, however.

The researchers recruited some participants from the Dallas Heart Study--a multi-ethnic, population-based study of more than 6,000 patients in Dallas County designed to examine cardiovascular disease. Some researchers, including those at UT Southwestern, believe that as an individual becomes overweight, fat builds up in normal fat cells, but eventually fat cells cannot store fat any more. Ultimately, the excess of fat kills other cells--a theory backed up by a recent study by Dr. Unger in laboratory mice.


Related Links:
University of Texas Southwestern Medical Center

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.